HEADER OXIDOREDUCTASE 17-MAR-06 2GDZ TITLE CRYSTAL STRUCTURE OF 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE TYPE1, TITLE 2 COMPLEXED WITH NAD+ COMPND MOL_ID: 1; COMPND 2 MOLECULE: NAD+-DEPENDENT 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES (-1)-265; COMPND 5 SYNONYM: 15 HYDROXYPROSTAGLANDIN DEHYDROGENASE TYPE1; COMPND 6 EC: 1.1.1.141; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21-R3; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-SGC KEYWDS HYDROXYPROSTAGLANDIN, DEHYDROGENASE, STRUCTURAL GENOMICS, SHORT-CHAIN KEYWDS 2 DEHYDROGENASE/REDUCTASE, INFLAMMATION, STRUCTURAL GENOMICS KEYWDS 3 CONSORTIUM, SGC, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR E.S.PILKA,K.GUO,K.KAVANAGH,F.VON DELFT,C.ARROWSMITH,J.WEIGELT, AUTHOR 2 A.EDWARDS,M.SUNDSTROM,U.OPPERMANN,STRUCTURAL GENOMICS CONSORTIUM AUTHOR 3 (SGC) REVDAT 5 25-OCT-23 2GDZ 1 REMARK SEQADV REVDAT 4 13-JUL-11 2GDZ 1 VERSN REVDAT 3 24-NOV-10 2GDZ 1 JRNL REVDAT 2 24-FEB-09 2GDZ 1 VERSN REVDAT 1 04-APR-06 2GDZ 0 JRNL AUTH F.H.NIESEN,L.SCHULTZ,A.JADHAV,C.BHATIA,K.GUO,D.J.MALONEY, JRNL AUTH 2 E.S.PILKA,M.WANG,U.OPPERMANN,T.D.HEIGHTMAN,A.SIMEONOV JRNL TITL HIGH-AFFINITY INHIBITORS OF HUMAN NAD-DEPENDENT JRNL TITL 2 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE: MECHANISMS OF JRNL TITL 3 INHIBITION AND STRUCTURE-ACTIVITY RELATIONSHIPS. JRNL REF PLOS ONE V. 5 13719 2010 JRNL REFN ESSN 1932-6203 JRNL PMID 21072165 JRNL DOI 10.1371/JOURNAL.PONE.0013719 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.86 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 28883 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1538 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1952 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.71 REMARK 3 BIN R VALUE (WORKING SET) : 0.3810 REMARK 3 BIN FREE R VALUE SET COUNT : 105 REMARK 3 BIN FREE R VALUE : 0.4420 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2026 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 299 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.57 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.38000 REMARK 3 B22 (A**2) : 0.38000 REMARK 3 B33 (A**2) : -0.77000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.104 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.103 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.063 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.826 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.965 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2136 ; 0.019 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2899 ; 1.627 ; 1.981 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 269 ; 5.284 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 92 ;39.233 ;25.652 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 372 ;12.522 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 7 ;20.858 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 332 ; 0.111 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1581 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1146 ; 0.205 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1484 ; 0.304 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 241 ; 0.141 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 92 ; 0.185 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 30 ; 0.119 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1365 ; 1.054 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2116 ; 1.489 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 887 ; 2.482 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 781 ; 3.736 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2GDZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 23-MAR-06. REMARK 100 THE DEPOSITION ID IS D_1000037000. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC REMARK 200 OPTICS : OSMIC REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30422 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 196.120 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 11.90 REMARK 200 R MERGE (I) : 0.07700 REMARK 200 R SYM (I) : 0.07700 REMARK 200 FOR THE DATA SET : 23.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : 0.68800 REMARK 200 R SYM FOR SHELL (I) : 0.68800 REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1WMB, 1IY8, 1ZK3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 PCB, 30% PEG 1000, PH 8.0, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 97.88550 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 24.77000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 24.77000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 48.94275 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 24.77000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 24.77000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 146.82825 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 24.77000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 24.77000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 48.94275 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 24.77000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 24.77000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 146.82825 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 97.88550 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE SECOND PART OF THE BIOLOGICAL ASSEMBLY IS GENERATED REMARK 300 BY THE FOLLOWING SYMMETRY OPERATION: Y, X, -Z + (0 0 1) REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 7160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -53.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 195.77100 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 54 CD OE1 OE2 REMARK 470 GLU A 205 CD OE1 OE2 REMARK 470 LYS A 215 CD CE NZ REMARK 470 ASP A 236 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 96 103.54 -161.69 REMARK 500 SER A 137 -138.18 -94.32 REMARK 500 GLN A 148 57.18 -143.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 300 DBREF 2GDZ A 3 256 UNP P15428 PGDH_HUMAN 3 256 SEQADV 2GDZ MET A -1 UNP P15428 EXPRESSION TAG SEQADV 2GDZ ALA A 0 UNP P15428 EXPRESSION TAG SEQADV 2GDZ HIS A 1 UNP P15428 EXPRESSION TAG SEQADV 2GDZ MET A 2 UNP P15428 EXPRESSION TAG SEQADV 2GDZ GLY A 257 UNP P15428 EXPRESSION TAG SEQADV 2GDZ SER A 258 UNP P15428 EXPRESSION TAG SEQADV 2GDZ LYS A 259 UNP P15428 EXPRESSION TAG SEQADV 2GDZ GLU A 260 UNP P15428 EXPRESSION TAG SEQADV 2GDZ ASN A 261 UNP P15428 EXPRESSION TAG SEQADV 2GDZ LEU A 262 UNP P15428 EXPRESSION TAG SEQADV 2GDZ TYR A 263 UNP P15428 EXPRESSION TAG SEQADV 2GDZ PHE A 264 UNP P15428 EXPRESSION TAG SEQADV 2GDZ GLN A 265 UNP P15428 EXPRESSION TAG SEQRES 1 A 267 MET ALA HIS MET VAL ASN GLY LYS VAL ALA LEU VAL THR SEQRES 2 A 267 GLY ALA ALA GLN GLY ILE GLY ARG ALA PHE ALA GLU ALA SEQRES 3 A 267 LEU LEU LEU LYS GLY ALA LYS VAL ALA LEU VAL ASP TRP SEQRES 4 A 267 ASN LEU GLU ALA GLY VAL GLN CYS LYS ALA ALA LEU HIS SEQRES 5 A 267 GLU GLN PHE GLU PRO GLN LYS THR LEU PHE ILE GLN CYS SEQRES 6 A 267 ASP VAL ALA ASP GLN GLN GLN LEU ARG ASP THR PHE ARG SEQRES 7 A 267 LYS VAL VAL ASP HIS PHE GLY ARG LEU ASP ILE LEU VAL SEQRES 8 A 267 ASN ASN ALA GLY VAL ASN ASN GLU LYS ASN TRP GLU LYS SEQRES 9 A 267 THR LEU GLN ILE ASN LEU VAL SER VAL ILE SER GLY THR SEQRES 10 A 267 TYR LEU GLY LEU ASP TYR MET SER LYS GLN ASN GLY GLY SEQRES 11 A 267 GLU GLY GLY ILE ILE ILE ASN MET SER SER LEU ALA GLY SEQRES 12 A 267 LEU MET PRO VAL ALA GLN GLN PRO VAL TYR CYS ALA SER SEQRES 13 A 267 LYS HIS GLY ILE VAL GLY PHE THR ARG SER ALA ALA LEU SEQRES 14 A 267 ALA ALA ASN LEU MET ASN SER GLY VAL ARG LEU ASN ALA SEQRES 15 A 267 ILE CYS PRO GLY PHE VAL ASN THR ALA ILE LEU GLU SER SEQRES 16 A 267 ILE GLU LYS GLU GLU ASN MET GLY GLN TYR ILE GLU TYR SEQRES 17 A 267 LYS ASP HIS ILE LYS ASP MET ILE LYS TYR TYR GLY ILE SEQRES 18 A 267 LEU ASP PRO PRO LEU ILE ALA ASN GLY LEU ILE THR LEU SEQRES 19 A 267 ILE GLU ASP ASP ALA LEU ASN GLY ALA ILE MET LYS ILE SEQRES 20 A 267 THR THR SER LYS GLY ILE HIS PHE GLN ASP TYR GLY SER SEQRES 21 A 267 LYS GLU ASN LEU TYR PHE GLN HET NAD A 300 44 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE FORMUL 2 NAD C21 H27 N7 O14 P2 FORMUL 3 HOH *299(H2 O) HELIX 1 1 GLN A 15 LYS A 28 1 14 HELIX 2 2 ASN A 38 HIS A 50 1 13 HELIX 3 3 GLU A 54 GLN A 56 5 3 HELIX 4 4 ASP A 67 GLY A 83 1 17 HELIX 5 5 ASN A 99 LEU A 108 1 10 HELIX 6 6 LEU A 108 SER A 123 1 16 HELIX 7 7 LYS A 124 GLY A 127 5 4 HELIX 8 8 SER A 138 LEU A 142 5 5 HELIX 9 9 GLN A 148 ASN A 173 1 26 HELIX 10 10 THR A 188 SER A 193 1 6 HELIX 11 11 LYS A 196 GLY A 201 1 6 HELIX 12 12 GLN A 202 GLU A 205 5 4 HELIX 13 13 TYR A 206 GLY A 218 1 13 HELIX 14 14 ASP A 221 ASP A 235 1 15 HELIX 15 15 ASN A 261 GLN A 265 5 5 SHEET 1 A 8 THR A 58 GLN A 62 0 SHEET 2 A 8 LYS A 31 ASP A 36 1 N LEU A 34 O LEU A 59 SHEET 3 A 8 VAL A 7 THR A 11 1 N ALA A 8 O ALA A 33 SHEET 4 A 8 ILE A 87 ASN A 90 1 O VAL A 89 N LEU A 9 SHEET 5 A 8 GLY A 131 MET A 136 1 O ILE A 134 N LEU A 88 SHEET 6 A 8 VAL A 176 PRO A 183 1 O ARG A 177 N ILE A 133 SHEET 7 A 8 ILE A 242 THR A 246 1 O MET A 243 N CYS A 182 SHEET 8 A 8 GLY A 250 PHE A 253 -1 O HIS A 252 N LYS A 244 SITE 1 AC1 32 GLY A 12 GLN A 15 GLY A 16 ILE A 17 SITE 2 AC1 32 ASP A 36 TRP A 37 CYS A 63 ASP A 64 SITE 3 AC1 32 VAL A 65 ASN A 91 ALA A 92 GLY A 93 SITE 4 AC1 32 VAL A 94 ILE A 106 SER A 137 SER A 138 SITE 5 AC1 32 TYR A 151 LYS A 155 PRO A 183 GLY A 184 SITE 6 AC1 32 PHE A 185 VAL A 186 THR A 188 ALA A 189 SITE 7 AC1 32 ILE A 190 HOH A 304 HOH A 313 HOH A 325 SITE 8 AC1 32 HOH A 378 HOH A 383 HOH A 434 HOH A 441 CRYST1 49.540 49.540 195.771 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020186 0.000000 0.000000 0.00000 SCALE2 0.000000 0.020186 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005108 0.00000